BERTHA BARRAZA: Open Payments
NPI 1043769342 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 60 payments from 13 companies in 2025. Trend: 2023 $57 · 2024 $651 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 28 | $335 |
| Janssen Pharmaceuticals, Inc | 7 | $186 |
| Amgen Inc. | 8 | $145 |
| Neurocrine BioSciences, Inc. | 2 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $35 |
| Lilly USA, LLC | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $22 |
Products named: IBSRELA, INVEGA SUSTENNA, INGREZZA, REPATHA, CAPLYTA, OTEZLA, COBENFY, REXULTI.
Industry payments across CA — which companies pay providers there.
